Actinium Pharmaceuticals, Inc. (ATNM)
EBITDA Margin
34.71%
TTM · Period ending:
ATNM EBITDA Margin
Latest reported34.71%period ending
Latest reported34.71%period ending
ATNM EBITDA Margin (0.00% → 34.71%)
Annual ebitda margin
High-resolution chart · PNG
ATNM ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -36,740% | |
| 0% | |
| -59,293.8272% | |
| -3,137.6699% | |
| -2,119.7552% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |